https://www.selleckchem.com/pr....oducts/Paclitaxel(Ta
In total 91% (182/199) of approached patients consented to participate in the study and 98% (n=179) successfully completed the survey. Surveillance benefits (importance 51.3%, 95%CI 49.0-53.4%) were valued more than risk of physical harm (importance 7.6%, 95%CI 7.0-8.2%), financial harm (importance 15.2%, 95%CI 14.0-16.3%), convenience (importance 9.3%, 95%CI 8.5-10.1%) and test logistics (importance 16.7%, 95%CI 15.4-18.1%). Based on simulations including all possible tests, patients preferred abbreviated MRI (29.0%), MRI (23
Like
Comment
Share
